N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide

C126H130N24O21S12 — CID 159127968

IUPACN-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide
SMILESCc1nc(N(C)C(=O)C2(C)Cc3ccc(-c4ccccn4)cc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2(CO)Cc3ccc(-c4ccccn4)cc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2CCOc3cc(-c4ccccn4)ccc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2CCc3cc(-c4ccccn4)ccc3O2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2Cc3ccc(-c4ccccn4)cc3C2)sc1S(=O)(=O)NC1CC1.Cc1nc(N(C)C(=O)C2Cc3cccc(-c4ccccn4)c3C2)sc1S(N)(=O)=O
InChIInChI=1S/C23H24N4O3S2.2C21H22N4O4S2.C21H22N4O3S2.C20H20N4O4S2.C20H20N4O3S2/c1-14-22(32(29,30)26-19-8-9-19)31-23(25-14)27(2)21(28)18-11-15-6-7-16(12-17(15)13-18)20-5-3-4-10-24-20;1-13-20(31(22,27)28)30-21(24-13)25(2)19(26)16-8-10-29-18-12-14(6-7-15(18)11-16)17-5-3-4-9-23-17;1-13-18(31(22,28)29)30-20(24-13)25(2)19(27)21(12-26)10-15-7-6-14(9-16(15)11-21)17-5-3-4-8-23-17;1-13-18(30(22,27)28)29-20(24-13)25(3)19(26)21(2)11-15-8-7-14(10-16(15)12-21)17-6-4-5-9-23-17;1-12-19(30(21,26)27)29-20(23-12)24(2)18(25)17-9-7-14-11-13(6-8-16(14)28-17)15-5-3-4-10-22-15;1-12-19(29(21,26)27)28-20(23-12)24(2)18(25)14-10-13-6-5-7-15(16(13)11-14)17-8-3-4-9-22-17/h3-7,10,12,18-19,26H,8-9,11,13H2,1-2H3;3-7,9,12,16H,8,10-11H2,1-2H3,(H2,22,27,28);3-9,26H,10-12H2,1-2H3,(H2,22,28,29);4-10H,11-12H2,1-3H3,(H2,22,27,28);3-6,8,10-11,17H,7,9H2,1-2H3,(H2,21,26,27);3-9,14H,10-11H2,1-2H3,(H2,21,26,27)
InChIKeyKGNBTERCLVJSOF-UHFFFAOYSA-N
MW2701.38 g/mol
LogP15.98
Rot. Bonds27

About N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide

N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide (PubChem CID 159127968) has the molecular formula C126H130N24O21S12 and a molecular weight of 2701.38 g/mol. Its IUPAC name is N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide.

Molecular Properties

Compound NameN-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide
PubChem CID159127968
Molecular FormulaC126H130N24O21S12
Molecular Weight2701.38 g/mol
Exact Mass2698.65
IUPAC NameN-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide
SMILESCc1nc(N(C)C(=O)C2(C)Cc3ccc(-c4ccccn4)cc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2(CO)Cc3ccc(-c4ccccn4)cc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2CCOc3cc(-c4ccccn4)ccc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2CCc3cc(-c4ccccn4)ccc3O2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2Cc3ccc(-c4ccccn4)cc3C2)sc1S(=O)(=O)NC1CC1.Cc1nc(N(C)C(=O)C2Cc3cccc(-c4ccccn4)c3C2)sc1S(N)(=O)=O
InChIInChI=1S/C23H24N4O3S2.2C21H22N4O4S2.C21H22N4O3S2.C20H20N4O4S2.C20H20N4O3S2/c1-14-22(32(29,30)26-19-8-9-19)31-23(25-14)27(2)21(28)18-11-15-6-7-16(12-17(15)13-18)20-5-3-4-10-24-20;1-13-20(31(22,27)28)30-21(24-13)25(2)19(26)16-8-10-29-18-12-14(6-7-15(18)11-16)17-5-3-4-9-23-17;1-13-18(31(22,28)29)30-20(24-13)25(2)19(27)21(12-26)10-15-7-6-14(9-16(15)11-21)17-5-3-4-8-23-17;1-13-18(30(22,27)28)29-20(24-13)25(3)19(26)21(2)11-15-8-7-14(10-16(15)12-21)17-6-4-5-9-23-17;1-12-19(30(21,26)27)29-20(23-12)24(2)18(25)17-9-7-14-11-13(6-8-16(14)28-17)15-5-3-4-10-22-15;1-12-19(29(21,26)27)28-20(23-12)24(2)18(25)14-10-13-6-5-7-15(16(13)11-14)17-8-3-4-9-22-17/h3-7,10,12,18-19,26H,8-9,11,13H2,1-2H3;3-7,9,12,16H,8,10-11H2,1-2H3,(H2,22,27,28);3-9,26H,10-12H2,1-2H3,(H2,22,28,29);4-10H,11-12H2,1-3H3,(H2,22,27,28);3-6,8,10-11,17H,7,9H2,1-2H3,(H2,21,26,27);3-9,14H,10-11H2,1-2H3,(H2,21,26,27)
InChIKeyKGNBTERCLVJSOF-UHFFFAOYSA-N
XLogP15.98
TPSA662.20 Ų
H-Bond Donors7
H-Bond Acceptors39
Rotatable Bonds27
Heavy Atoms183
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002701.38
LogP ≤ 515.98
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1039

Analyze N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[1-(5-fluoro-6-pyridin-2-yl-2,3-dihydro-1H-inden-2-yl)ethyl-methylamino]-4-methyl-1,3-thiazole-5-sulfonamide;methane;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-2,3-dihydro-1H-indene-1-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yloxy-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-1,2,3,4-tetrahydronaphthalene-1-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-7-pyridin-2-yl-1,2,3,4-tetrahydronaphthalene-2-carboxamide
CID 158253322
N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-2,3-dihydro-1-benzofuran-3-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-3-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroisoindole-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-7-pyridin-2-yl-3,4-dihydro-1H-isoquinoline-2-carboxamide;N,3,3-trimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-1H-isoindole-2-carboxamide
CID 161369691

Frequently Asked Questions

What is the IUPAC name of N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide?
The IUPAC name of N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide (CID 159127968) is N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide.
What is the SMILES notation for N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide?
The canonical SMILES for N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide is Cc1nc(N(C)C(=O)C2(C)Cc3ccc(-c4ccccn4)cc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2(CO)Cc3ccc(-c4ccccn4)cc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2CCOc3cc(-c4ccccn4)ccc3C2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2CCc3cc(-c4ccccn4)ccc3O2)sc1S(N)(=O)=O.Cc1nc(N(C)C(=O)C2Cc3ccc(-c4ccccn4)cc3C2)sc1S(=O)(=O)NC1CC1.Cc1nc(N(C)C(=O)C2Cc3cccc(-c4ccccn4)c3C2)sc1S(N)(=O)=O.
What is the InChIKey of N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide?
The InChIKey is KGNBTERCLVJSOF-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24N4O3S2.2C21H22N4O4S2.C21H22N4O3S2.C20H20N4O4S2.C20H20N4O3S2/c1-14-22(32(29,30)26-19-8-9-19)31-23(25-14)27(2)21(28)18-11-15-6-7-16(12-17(15)13-18)20-5-3-4-10-24-20;1-13-20(31(22,27)28)30-21(24-13)25(2)19(26)16-8-10-29-18-12-14(6-7-15(18)11-16)17-5-3-4-9-23-17;1-13-18(31(22,28)29)30-20(24-13)25(2)19(27)21(12-26)10-15-7-6-14(9-16(15)11-21)17-5-3-4-8-23-17;1-13-18(30(22,27)28)29-20(24-13)25(3)19(26)21(2)11-15-8-7-14(10-16(15)12-21)17-6-4-5-9-23-17;1-12-19(30(21,26)27)29-20(23-12)24(2)18(25)17-9-7-14-11-13(6-8-16(14)28-17)15-5-3-4-10-22-15;1-12-19(29(21,26)27)28-20(23-12)24(2)18(25)14-10-13-6-5-7-15(16(13)11-14)17-8-3-4-9-22-17/h3-7,10,12,18-19,26H,8-9,11,13H2,1-2H3;3-7,9,12,16H,8,10-11H2,1-2H3,(H2,22,27,28);3-9,26H,10-12H2,1-2H3,(H2,22,28,29);4-10H,11-12H2,1-3H3,(H2,22,27,28);3-6,8,10-11,17H,7,9H2,1-2H3,(H2,21,26,27);3-9,14H,10-11H2,1-2H3,(H2,21,26,27).
What are the key properties of N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide?
N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide has a molecular weight of 2701.38 g/mol, XLogP of 15.98, 27 rotatable bonds, 7 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(cyclopropylsulfamoyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-5-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N,2-dimethyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;2-(hydroxymethyl)-N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-5-pyridin-2-yl-1,3-dihydroindene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-6-pyridin-2-yl-3,4-dihydro-2H-chromene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-4-pyridin-2-yl-2,3-dihydro-1H-indene-2-carboxamide;N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-8-pyridin-2-yl-2,3,4,5-tetrahydro-1-benzoxepine-4-carboxamide is sourced from PubChem (CID 159127968), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).